Skip to main content
Springer logoLink to Springer
. 2020 Sep 2;39(10):3161. doi: 10.1007/s10067-020-05356-1

Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data

Chak Sing Lau 1,, Yi-Hsing Chen 2, Keith Lim 3, Marc de Longueville 4, Catherine Arendt 4, Kevin Winthrop 5
PMCID: PMC8025280  PMID: 32876785

Correction to: Clinical Rheumatology

10.1007/s10067-020-05248-4

The original published version of the above article contained an error. In the Statistical Analysis section, a minus symbol was use instead of a hyphen in the term “patient-years.” The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1007/s10067-020-05248-4

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Clinical Rheumatology are provided here courtesy of Springer

RESOURCES